EP2493442A4 - Dispositifs, méthodes et composition permettant de lutter contre les infections - Google Patents

Dispositifs, méthodes et composition permettant de lutter contre les infections

Info

Publication number
EP2493442A4
EP2493442A4 EP10828816.8A EP10828816A EP2493442A4 EP 2493442 A4 EP2493442 A4 EP 2493442A4 EP 10828816 A EP10828816 A EP 10828816A EP 2493442 A4 EP2493442 A4 EP 2493442A4
Authority
EP
European Patent Office
Prior art keywords
composition
methods
devices
controlling infections
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP10828816.8A
Other languages
German (de)
English (en)
Other versions
EP2493442A2 (fr
Inventor
Paul J Rucinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovation Technologies Inc
Original Assignee
Innovation Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovation Technologies Inc filed Critical Innovation Technologies Inc
Publication of EP2493442A2 publication Critical patent/EP2493442A2/fr
Publication of EP2493442A4 publication Critical patent/EP2493442A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
EP10828816.8A 2009-10-26 2010-10-24 Dispositifs, méthodes et composition permettant de lutter contre les infections Ceased EP2493442A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25490609P 2009-10-26 2009-10-26
PCT/US2010/053884 WO2011056486A2 (fr) 2009-10-26 2010-10-24 Dispositifs, méthodes et composition permettant de lutter contre les infections

Publications (2)

Publication Number Publication Date
EP2493442A2 EP2493442A2 (fr) 2012-09-05
EP2493442A4 true EP2493442A4 (fr) 2013-05-15

Family

ID=43970646

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10828816.8A Ceased EP2493442A4 (fr) 2009-10-26 2010-10-24 Dispositifs, méthodes et composition permettant de lutter contre les infections

Country Status (5)

Country Link
EP (1) EP2493442A4 (fr)
JP (1) JP2013508457A (fr)
CN (1) CN102711709A (fr)
CA (1) CA2778081A1 (fr)
WO (1) WO2011056486A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5872430B2 (ja) * 2012-09-20 2016-03-01 日本電子照射サービス株式会社 グルコン酸クロルヘキシジン製剤、消毒用キット及び滅菌方法
US10016375B2 (en) 2013-12-12 2018-07-10 Paul J. Rucinski Materials and methods for controlling infections
RU2682642C1 (ru) 2013-12-12 2019-03-20 Инновейшн Текнолоджиз, Инк. Материалы и способы борьбы c инфекциями
US20160038442A1 (en) * 2014-08-08 2016-02-11 Innovation Technologies, Inc. Materials and methods for controlling infections with negative pressure wound therapy

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017516A (en) * 1997-10-31 2000-01-25 Lekar Pharma Limited Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate
US20050191247A1 (en) * 2004-03-01 2005-09-01 David Drake Chlorhexidine compositions
US20070036846A1 (en) * 2005-08-15 2007-02-15 Tsang Wing W M Wound dressing and method of manufacture thereof
KR20090106477A (ko) * 2006-12-19 2009-10-09 이노베이션 테크놀로지스, 인코포레이티드 활성제를 표적 부위로 전달하기 위한 장치 및 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616208D0 (en) * 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
US20040185028A1 (en) * 2003-03-19 2004-09-23 Zhenze Hu Antimicrobial compositions containing ethanolamine buffer and biguanide disinfectant
US20050113794A1 (en) * 2003-09-22 2005-05-26 Rucinski Paul J. Novel wound irrigation device and method
US20050124946A1 (en) * 2003-12-05 2005-06-09 Sergio Landau Wound irrigation apparatus and method
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
JP2006117587A (ja) * 2004-10-22 2006-05-11 Dainippon Sumitomo Pharma Co Ltd 殺菌消毒剤組成物
US7540860B2 (en) * 2006-01-23 2009-06-02 Keith Stamler Wound irrigation splashback shield

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017516A (en) * 1997-10-31 2000-01-25 Lekar Pharma Limited Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate
US20050191247A1 (en) * 2004-03-01 2005-09-01 David Drake Chlorhexidine compositions
US20070036846A1 (en) * 2005-08-15 2007-02-15 Tsang Wing W M Wound dressing and method of manufacture thereof
KR20090106477A (ko) * 2006-12-19 2009-10-09 이노베이션 테크놀로지스, 인코포레이티드 활성제를 표적 부위로 전달하기 위한 장치 및 방법

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Chlorhexidine andCetrimide IrrigationSolution", CONSUMER MEDICINE INFORMATION, September 1996 (1996-09-01), pages 1 - 2, XP002694789, Retrieved from the Internet <URL:http://www.betterhealth.vic.gov.au/bhcv2/bhcmed.nsf/ad41b722944269b34a256b4800020946/73f7a5de056f6bcbca257b3600107b78/$FILE/pucchcet.pdf> [retrieved on 20130404] *

Also Published As

Publication number Publication date
EP2493442A2 (fr) 2012-09-05
CN102711709A (zh) 2012-10-03
WO2011056486A3 (fr) 2011-09-29
CA2778081A1 (fr) 2011-05-12
JP2013508457A (ja) 2013-03-07
WO2011056486A2 (fr) 2011-05-12

Similar Documents

Publication Publication Date Title
HK1250936A1 (zh) 用於治療病毒感染的化合物和方法
HK1247841A1 (zh) 苯並氧雜硼雜環戊二烯衍生物用於治療細菌感染
WO2011056650A9 (fr) Méthodes et compositions utilisées dans le cadre du traitement et de la prévention d&#39;infections virales
ZA201208578B (en) Composition,method and use
IL225597A0 (en) Pharmaceutical preparation, methods of treatment and its uses
GB0917044D0 (en) Agents, uses and methods
GB0917054D0 (en) Agents, uses and methods
EP2335320A4 (fr) Isolateurs dielectriques
EP2490530A4 (fr) Composés et méthodes pour le traitement d&#39;infections bactériennes
EP2527404A4 (fr) Composition pour élément résorbable aux rayons ultraviolets, et élément résorbable aux rayons ultraviolets comprenant celle-ci
EP2445067A4 (fr) Composition de remplissage d&#39;espace de décharge, et dispositif de protection contre les décharges électrostatiques
GB0919591D0 (en) Controlling communications
EP2505644A4 (fr) Composition de régulation de l&#39;atmosphère
GB0919592D0 (en) Controlling communications
GB0919441D0 (en) Controlling bandwidth share
GB201103931D0 (en) Printable composition, method and uses thereof
EP2424091A4 (fr) Dispositif de commutation et son procédé de commande
EP2437724A4 (fr) Compositions et méthodes pour prévenir les infections sternales de blessures
EP2493442A4 (fr) Dispositifs, méthodes et composition permettant de lutter contre les infections
GB201005571D0 (en) Method, composition, article and uses
EP2578659A4 (fr) Agent conférant hydrophobicité et oléophobicité, et composition d&#39;agent conférant hydrophobicité et oléophobicité
PL2263454T3 (pl) Kompozycja uzdatniająca
EP2417154A4 (fr) Interaction récepteur d2 de la dopamine-disc1, compositions et procédés pour moduler celle-ci
IL216957A0 (en) Exo-s-mecamylamine method, use, and compound for treatment
GB0901234D0 (en) Composition,method and use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120419

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1170928

Country of ref document: HK

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 31/00 20060101ALI20130404BHEP

Ipc: A61K 31/35 20060101ALI20130404BHEP

Ipc: A61M 25/00 20060101ALI20130404BHEP

Ipc: A61J 1/05 20060101AFI20130404BHEP

Ipc: A61L 2/18 20060101ALI20130404BHEP

Ipc: A61L 101/32 20060101ALI20130404BHEP

Ipc: A61M 35/00 20060101ALI20130404BHEP

Ipc: A61M 37/00 20060101ALI20130404BHEP

Ipc: A61P 31/00 20060101ALI20130404BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20130415

17Q First examination report despatched

Effective date: 20140527

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

APAV Appeal reference deleted

Free format text: ORIGINAL CODE: EPIDOSDREFNE

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20170901